TransDigm Outpaces Peers Before Tuesday's Print

TDG gained 4.4% over the past week, closing at $1,197.01. That comfortably beat a median gain of roughly 2% across its closest peers: HEI added only 0.3%, GE 0.5%, and RTX fell 3.8%. Only LOAR, up 12.6%, moved more decisively. The lending market reflects no particular conviction on the short side: availability is extremely loose at over 7,400%, meaning there are vastly more shares available to borrow than are currently shorted. Short interest has also declined, falling roughly 8% over the past month to 1.8% of the free float, with borrowing costs running below 0.5%. Options positioning has drifted more cautious over the past fortnight, with the put/call ratio at 1.27 against a 20-day average of 1.19, though the z-score of 0.22 puts that well within normal range.

The analyst community has been trimming price targets broadly in the weeks leading up to the print, with Morgan Stanley, RBC Capital, Goldman Sachs, TD Cowen, and Wells Fargo all cutting their numbers since late September, even as most kept their ratings unchanged. Goldman maintained a Buy with a target of $1,745, while Morgan Stanley held Equal-Weight at $1,300 and RBC kept Sector Perform at $1,200. The mean consensus target is $1,414, implying roughly 18% upside from current levels, though that figure reflects the September and October rounds of cuts rather than any fresh read post-earnings. The core debate is straightforward: bulls point to strong commercial OE growth, 160 basis points of margin expansion to 54.2%, and durable aftermarket demand across both commercial and defense. Bears focus on the FY2026 EBITDA guidance of $5.15 billion, which came in below consensus, with margin expected to decline 140 basis points year-on-year from the dilutive effect of the Simmonds acquisition and a less favorable product mix. At 21.7x trailing earnings and an EV/EBITDA of 14x, the stock carries a premium that leaves little room for further guidance disappointment.

One ownership detail worth noting: the activist register carries no 13D filers. The Vanguard Group filed an amended 13G in March 2026 showing its stake had fallen to zero from 11.9% previously. A separate Vanguard Capital Management entity subsequently filed a fresh 13G in April at 7.48%, and Capital International Investors disclosed 9.9%. These are passive 13G holders, all as-last-disclosed around the 5% threshold, and any may have moved since filing. Insider activity was confined to the Co-Chief Operating Officer in mid-October, all executed under a pre-arranged 10b5-1 plan and therefore carrying limited informational weight. The net 90-day insider position is a modest sale of roughly $5.5 million in value.

Tuesday's print will test whether the aftermarket trajectory has stabilised enough to support the valuation premium, and whether the Simmonds margin drag is tracking in line with the guidance already baked in.